Page 14 - இந்தியன் நிறுவனம் ஆஃப் பொது ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Centre on Tuesday waived clinical trial preconditions for emergency use authorisation of Covid-19 vaccines approved by select foreign regulatory agencies, seeking to augment India’s vaccine basket and accelerate the inoculation campaign. The Union health ministry has accepted the recommendations of an expert panel to expedite emergency use authorisation of vaccines already approved by the US Food and Drug Administration, the European Medicines Agency, the regulatory agencies of Japan and the UK, and those listed by the World Health Organisation. The move, advocated for weeks by sections of health experts, opens a window of opportunity for companies such as Pfizer, Moderna, and Johnson and Johnson to introduce their vaccines in India without the mandatory local clinical trials, health officials said.

United kingdomWest bengalVinod paulGiridhar babuSantanu tripathiCentre onDrug administrationCalcutta school of tropical medicineIndian institute of public healthWorld health organisationEuropean medicines agencySerum institute of indiaWorld healthNational expert groupVaccine administrationNiti aayog